Infrastructure Investment Plan 2021-22 to 2025-26: programme pipeline update - March 2022

Sector: Health

Programme name: National Treatment Centres

Programme description: New Diagnostic and Treatment Centres to allow people to be treated more quickly for planned surgery. The programme will encompass the provision of additional elective capacity across 10 National Treatment Centres (NTCs) in 9 Health Boards to cover the all-Scotland requirement out to 2035. This will require new build as well as refurbishment of existing infrastructure.

Estimated total investment: Over £600 million.

How is programme being funded: Capital funded.

Programme delivery timetable: Delivery of all units is expected to be completed in 2027.

Latest programme progress: The estimated total investment has increased from £570 million to £600 million due to industry price increases and Net Zero Carbon requirements affecting projects in development.

• Building work has completed on the Golden Jubilee National Hospital's Phase 1 Ophthalmology Unit Development and the unit became operational in November 2020
• NTC - Highland is under construction. Enabling work commenced in July 2020 with main works commencing in January 2021. Completion is expected late 2022
• Main construction works have started at the Golden Jubilee National Hospital's Phase 2. Construction is expected to be completed by mid-2023
• Main construction works on NTC - Fife began on 1 March 2021 and are expected to be completed by late 2022
• Outline Business Case (OBC) for the NTC - Lothian at St John's Hospital in Livingston has been approved and NHS Lothian are in the process of developing their FBC
• NTC - Grampian concluding a clinically led review of the scope of the project. Revised dates for the project plan will be confirmed following completion of this review
• NTC - Tayside OBC is expected to be submitted for review in early 2023
• NTC - Forth Valley project to increase Elective Care capacity in NHS Forth Valley is scheduled to be completed by end of 2022
• NTC - Ayrshire and Arran is progressing towards Full Business Case submission
• NTC - Lanarkshire project is at the early stage of planning and will progress towards an Initial Agreement
• NHS Lothian's replacement for the Edinburgh Eye Pavilion is now an integral part of the NTC programme and NHS Lothian are working towards a Full Business Case submission

Contribution to economic development: Each of these projects (except NTC - Forth Valley) will utilise a Project Bank Account. The NTC programme will support at least 1,500 new NHS jobs. Each project will provide a number of Community Benefits delivered as a requirement of the Principal Supply Chain Partners appointment.

Contact for public enquiries: email: Margaret.Sherwood@gov.scot

Programme name: eHealth

Programme description: HEPMA National Implementation Programme.

Estimated total investment: £24 million (2016-2025 with c£2.4 million still to be allocated).

How is programme being funded: Capital and revenue funded.

Programme delivery timetable: 2022-23 to 2024-25.

Latest programme progress: The implementation of HEPMA (Hospital Electronic Prescribing and Medicines Administration) has been ongoing for a number of years. A national Full Business Case (FBC) was produced and a national framework has been in place since 2016. Boards were tasked to look towards regional convergence which has been accepted as a significant challenge.

Due to the complexities involved, the regions (with the exception of the North) have moved towards a board by board roll-out with regional convergence as the longer term view. These complexities have led to significant delays in meeting the original FBC timeline and ultimately financial challenges due to the slow roll out. The launch of the Digital Health and Care Strategy has helped re-energise the programme with delivery across the county now being taken forward at pace. HEPMA has already been successfully implemented in six Health boards across Scotland and all remaining Health Boards all expected to roll it out by the end of 2025.

Contribution to economic development: The use of HEPMA can ensure the best value of public money by providing a range of benefits including: Accurate prescribing and administrations medicine; better communication between and within settings; greater consistency of clinical decision-making; better use of information; and improved use of medicines to enable transformation of clinical services and releasing staff time to care and efficiency.

Contact for public enquiries: email: francis.santos@gov.scot